---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-108417"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2026-09-17T11:18:22+00:00"
generated_at: "2026-09-17T11:20:07.853362+00:00"
event_type: "dividend"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Indivior declares $8.13/shr special dividend contingent on Supernus merger closing

## Summary
- Special dividend of $8.13 per share; record date October 30, 2026; payment expected ~November 6, 2026.
- Payment contingent on merger closing expected on or about November 2, 2026; no dividend if merger fails.
- Supernus stockholders ineligible for dividend on Indivior shares received in merger.
- Indivior expects majority of dividend to exceed current/accumulated earnings; treated as return of capital.

## SEC filing metadata
- accession: 0001104659-26-108417
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2026-09-17T11:18:22+00:00
- event_type: dividend
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000110465926108417/0001104659-26-108417-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000110465926108417/tm2623753d7_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-108417
- JSON: https://secwatch.observer/filing/0001104659-26-108417.json
- Plain text: https://secwatch.observer/filing/0001104659-26-108417.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.